EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Translation from Preclinical Research to Clinical Trials: Transdermal Drug Delivery for Neurodegenerative and Mental Disorders

Phuong-Trang Nguyen-Thi, Tuong Kha Vo, Huong Thuy Le, Nhat Thang Thi Nguyen, Thuy Trang Nguyen, Giau Van Vo

Pharmaceutical Research · 2024

DOI: 10.1007/s11095-024-03718-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutical Research, 2024. Verfasst von Phuong-Trang Nguyen-Thi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, HUTECH University, Ho Chi Minh City, 700000, Vietnam. Hauptthemen laut MEDLINE: Administration, Cutaneous, Neurodegenerative Diseases, Mental Disorders, Blood-Brain Barrier. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 369 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases (NDs), particularly dementia, provide significant problems to worldwide healthcare systems. The development of therapeutic materials for various diseases has a severe challenge in the form of the blood-brain barrier (BBB). Transdermal treatment has recently garnered widespread favor as an alternative method of delivering active chemicals to the brain. This approach has several advantages, including low invasiveness, self-administration, avoidance of first-pass metabolism, preservation of steady plasma concentrations, regulated release, safety, efficacy, and better patient compliance. Topics include the transdermal method for therapeutic NDs, their classification, and the mechanisms that allow the medicine to enter the bloodstream through the skin. The paper also discusses the obstacles and potential outcomes of transdermal therapy, emphasizing the benefits and drawbacks of different approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Administration, CutaneousNeurodegenerative DiseasesMental DisordersBlood-Brain BarrierDrug Delivery SystemsHumansAnimalsTranslational Research, BiomedicalClinical Trials as TopicSkinSkin Absorption

Stichwörter der Autor:innen

blood–brain barrierefficacymicroneedlesneurodegenerative diseasestransdermal

Autor:innen und Institutionen

  • Faculty of Pharmacy, HUTECH University, Ho Chi Minh City, 700000, Vietnam.
  • Department of Sports Medicine, University of Medicine and Pharmacy (VNU-UMP), Vietnam National University Hanoi, Hanoi, 100000, Vietnam.
  • Faculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City, 700000, Vietnam.
  • Faculty of Chemical Engineering, Industrial University of Ho Chi Minh City, Ho Chi Minh City, 71420, Vietnam. nguyenthinhatthang@iuh.edu.vn.
  • Faculty of Chemical Engineering, Industrial University of Ho Chi Minh City, Ho Chi Minh City, 71420, Vietnam.
  • Degenerative Diseases Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA. gvo@sbpdiscovery.org.

Zitieren

APA

Nguyen-Thi, P. T., Vo, T. K., Le, H. T., Nguyen, N. T. T., Nguyen, T. T., & Van Vo, G. (2024). Translation from Preclinical Research to Clinical Trials: Transdermal Drug Delivery for Neurodegenerative and Mental Disorders. Pharmaceutical Research. https://doi.org/10.1007/s11095-024-03718-x

Vancouver

Nguyen-Thi PT, Vo TK, Le HT, Nguyen NTT, Nguyen TT, Van Vo G. Translation from Preclinical Research to Clinical Trials: Transdermal Drug Delivery for Neurodegenerative and Mental Disorders. Pharmaceutical Research. 2024. doi:10.1007/s11095-024-03718-x

BibTeX
@article{NguyenThi2024,
  author = {Nguyen-Thi, Phuong-Trang and Vo, Tuong Kha and Le, Huong Thuy and Nguyen, Nhat Thang Thi and Nguyen, Thuy Trang and Van Vo, Giau},
  title = {Translation from Preclinical Research to Clinical Trials: Transdermal Drug Delivery for Neurodegenerative and Mental Disorders},
  journal = {Pharmaceutical Research},
  year = {2024},
  doi = {10.1007/s11095-024-03718-x}
}
Kostenlos starten →